Integrating Longitudinal ctDNA-Based MRD & PETCT for Earlier Detection of Response & Relapse in B-Cell Malignancies Compared with Imaging Alone

4:45 pm - Thursday 18th March 2027

  • Further details to be released

Speakers:

Andrew Steele
Senior Director - Global Precision Medicine Oncology Lead
Genmab